Talimogene Laherparepvec treatment for mucosal melanoma with metastatic lymph node metastasis: case report

Mucosal melanoma is a rare and aggressive subtype of melanoma, accounting for approximately 1% of all melanoma cases. Of those, only 4% occur primarily in the vagina. Talimogene Laherparepvec (T-VEC) is a biopharmaceutical medication that is used to treat unresectable malignant melanoma. However, th...

Full description

Bibliographic Details

Published in:	Frontiers in Oncology
Main Authors:	Arnar B. Ingason, Venkatesa P. Muruganandam, Ikechukwu Chidobem, Jessica Cintolo-Gonzalez, Hibba tul Rehman
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-10-01
Subjects:	mucosal melanoma malignant melanoma T-VEC immunotherapy lymphatic metastasis
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2025.1647603/full